111 related articles for article (PubMed ID: 23758283)
1. Glucagon underutilized among type 1 diabetes mellitus patients in Japan.
Murata T; Okazaki K; Yanagisawa K; Yamada K; Kuribayashi N; Totsuka Y; Hiyoshi T; Naka M; Sugimoto M; Aoki Y; Waki M; Furuya M; Kitaoka H; Oishi M; Shimizu I; Miyaoka H; Yamamoto T; Yamada K; Sakane N
Diabetes Technol Ther; 2013 Sep; 15(9):748-50. PubMed ID: 23758283
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia and Glucagon Utilization in Insulin-Treated Diabetic Patients.
Vilovic M; Kurir TT; Novak A; Krnic M; Borovac JA; Lizatovic IK; Kokic V; Bozic J
Exp Clin Endocrinol Diabetes; 2020 Aug; 128(8):493-498. PubMed ID: 30428496
[TBL] [Abstract][Full Text] [Related]
3. Glucagon as a treatment of severe hypoglycemia: safe and efficacious but underutilized.
Pearson T
Diabetes Educ; 2008; 34(1):128-34. PubMed ID: 18267999
[TBL] [Abstract][Full Text] [Related]
4. The prescription rates of glucagon for hypoglycemia by pediatricians and physicians are low in Japan.
Matsumoto M; Awano H; Hirota Y; Nagai M; Bo R; Matsuoka A; Hamaguchi T; Takeuchi T; Nakagawa Y; Ogawa W; Iijima K
Endocrine; 2019 May; 64(2):233-238. PubMed ID: 30367442
[TBL] [Abstract][Full Text] [Related]
5. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis.
Pontiroli AE; Tagliabue E
Acta Diabetol; 2020 Jun; 57(6):743-749. PubMed ID: 32025860
[TBL] [Abstract][Full Text] [Related]
6. Glucagon injection for type 1 diabetes in children.
Yardley D; Lyddall A; Richardson J; Timms H; Edwards J; Grint K; Jones A
Nurs Child Young People; 2011 Nov; 23(9):12-8. PubMed ID: 22164591
[TBL] [Abstract][Full Text] [Related]
7. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new training program to reassure primary school teachers about glucagon injection in children with type 1 diabetes during the 2017-2018 school year.
Tournilhac C; Dolladille C; Armouche S; Vial S; Brouard J
Arch Pediatr; 2020 May; 27(4):212-218. PubMed ID: 32284221
[TBL] [Abstract][Full Text] [Related]
10. The role of intramyocellular lipids during hypoglycemia in patients with intensively treated type 1 diabetes.
Bernroider E; Brehm A; Krssak M; Anderwald C; Trajanoski Z; Cline G; Shulman GI; Roden M
J Clin Endocrinol Metab; 2005 Oct; 90(10):5559-65. PubMed ID: 15998784
[TBL] [Abstract][Full Text] [Related]
11. [Psychometric analysis of the Spanish and Catalan versions of a questionnaire for hypoglycemia awareness].
Jansa M; Quirós C; Giménez M; Vidal M; Galindo M; Conget I
Med Clin (Barc); 2015 May; 144(10):440-4. PubMed ID: 24529399
[TBL] [Abstract][Full Text] [Related]
12. Role of glucagon in treating diabetes: evidence and concepts.
Bloomgarden Z
J Diabetes; 2014 Mar; 6(2):93-5. PubMed ID: 24224965
[No Abstract] [Full Text] [Related]
13. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
[TBL] [Abstract][Full Text] [Related]
14. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
Schiel R; Ulbrich S; Müller UA
Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
[TBL] [Abstract][Full Text] [Related]
15. Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy).
Trento M; Panero F; Porta M; Gruden G; Barutta F; Cerutti F; Gambino R; Perotto M; Cavallo Perin P; Bruno G;
Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1031-6. PubMed ID: 23466181
[TBL] [Abstract][Full Text] [Related]
16. Reversing severe hypoglycemia during pregnancy with glucagon therapy.
Rayburn W; Piehl E; Sanfield J; Compton A
Am J Perinatol; 1987 Jul; 4(3):259-61. PubMed ID: 3300677
[TBL] [Abstract][Full Text] [Related]
17. Individual and societal consequences of hypoglycemia: A cross-sectional survey.
Dømgaard M; Bagger M; Rhee NA; Burton CM; Thorsteinsson B
Postgrad Med; 2015 Jun; 127(5):438-45. PubMed ID: 25971530
[TBL] [Abstract][Full Text] [Related]
18. Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study.
Yale JF; Dulude H; Egeth M; Piché CA; Lafontaine M; Carballo D; Margolies R; Dissinger E; Shames AR; Kaplowitz N; Zhang MX; Zhang S; Guzman CB
Diabetes Technol Ther; 2017 Jul; 19(7):423-432. PubMed ID: 28556672
[TBL] [Abstract][Full Text] [Related]
19. Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis.
Pöhlmann J; Mitchell BD; Bajpai S; Osumili B; Valentine WJ
J Diabetes Sci Technol; 2019 Sep; 13(5):910-918. PubMed ID: 30700165
[TBL] [Abstract][Full Text] [Related]
20. Glucagon prescribing and prevention of hospitalization for hypoglycemia in a large health system.
Herges JR; Haag JD; Kosloski Tarpenning KA; Mara KC; McCoy RG
Diabetes Res Clin Pract; 2023 Aug; 202():110832. PubMed ID: 37453512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
